Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Fenofibrate
Trade Name
Lipanthyl 200 Micronized
Manufacturer
Laboratories Fournier
Risk Category
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • antilipemic agent.
  • Fetal Risk
    Fetal Risk
  • Embryodical, fetotoxic and teratogenic in animals at high doses causing increased post-implantation loss, decreased birth weight and post-natal survival, increased incidence of congenital malformations including: visceral, skeletal defects and spina bifida.
  • No adequate human data, should be used only if potential maternal benefit outweighs any risk to the fetus.
  • Breast Feeding
    Breast Feeding
  • Should not be used by lactating women because of the potential for tumorigenicity as seen in animal studies.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     9   +   10    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year